Sensulin is a diabetes drug discovery company developing a once-a-day glucose-responsive insulin.
Sensulin's investors include National Science Foundation, Propel(X), MassChallenge, Cortado Ventures, AngelMD.
Sensulin is headquartered in Oklahoma City, United States.
Sensulin is a diabetes drug discovery company developing a once-a-day glucose-responsive insulin.
Sensulin is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sensulin — Funding & Investors." VCBacked, October 25, 2021, https://www.vcbacked.co/company/sensulin. Accessed July 20, 2026.
VCBacked. (2021). Sensulin — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/sensulin
{{cite web |title=Sensulin — Funding & Investors |url=https://www.vcbacked.co/company/sensulin |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated